Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Am J Ophthalmol. 2012 Sep 5;154(6):934–939.e1. doi: 10.1016/j.ajo.2012.06.001

Table 2.

Comparison of 3-month best spectacle-corrected visual acuity (BSCVA) in Nocardia keratitis vs. non-Nocardia keratitis patients with a multivariate linear regression model

Covariate Coefficient (logMAR) 95% CI P-value
Nocardia spp (vs. all other organisms) 0.21 0.09 to 0.33 0.001
Corticosteroid (vs. placebo) −0.02 −0.09 to 0.06 0.64
Enrollment BSCVA (logMAR) 0.64 0.58 to 0.70 <0.001
HHS Vulnerability Disclosure